Cancer stem cell research in Iran: potentials and challenges

References

• Siegel RL , MillerKD, JemalA. Cancer statistics, 2015. CA Cancer J. Clin.65(1), 5–29 (2015).
   PubMed Web of Science ®Google Scholar
• Torre LA , BrayF, SiegelRLet al. Global cancer statistics, 2012. CA Cancer J. Clin.65(2), 87–108 (2015).
   PubMed Web of Science ®Google Scholar
• Salehiniya H , Ghobadi DashdebiS, RafiemaneshHet al. Time trend analysis of cancer incidence in Caspian sea, 2004–2009: a Population-based Cancer Registries Study (northern Iran). Caspian J. Intern. Med.7(1), 25–30 (2016).
   PubMedGoogle Scholar
• Mousavi SM , GouyaMM, RamazaniRet al. Cancer incidence and mortality in Iran. Ann. Oncol.20(3), 556–563 (2009).
   PubMed Web of Science ®Google Scholar
• Cojoc M , MäbertK, MudersMHet al. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin. Cancer Biol.31, 16–27 (2015).
   PubMed Web of Science ®Google Scholar
• Vlashi E , PajonkF. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin. Cancer Biol.31, 28–35 (2015).
   PubMed Web of Science ®Google Scholar
• Marjanovic ND , WeinbergRA, ChafferCL. Cell plasticity and heterogeneity in cancer. Clin. Chem.59(1), 168–179 (2013).
   PubMed Web of Science ®Google Scholar
• Soltanian S , MatinMM. Cancer stem cells and cancer therapy. Tumour Biol.32(3), 425–440 (2011).
   PubMed Web of Science ®Google Scholar
• Sugihara E , SayaH. Complexity of cancer stem cells. Int. J. Cancer132(6), 1249–1259 (2013).
   PubMed Web of Science ®Google Scholar
• Rich JN . Cancer stem cells: understanding tumor hierarchy and heterogeneity. Medicine (Baltimore)95(1S), S2–S7 (2016).
   PubMedGoogle Scholar
• Nassar D , BlanpainC. Cancer stem cells: basic concepts and therapeutic implications. Annu. Rev. Pathol.11, 47–76 (2016).
   PubMed Web of Science ®Google Scholar
• Rahman M , JamilHM, AkhtarNet al. Stem cell and cancer stem cell: a tale of two cells. Progress in Stem Cell3(2), 97–108 (2016).
   Google Scholar
• Bonnet D , DickJE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med.3(7), 730–737 (1997).
   PubMed Web of Science ®Google Scholar
• Al-Hajj M , WichaMS, Benito-HernandezAet al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA100(7), 3983–3988 (2003).
   PubMed Web of Science ®Google Scholar
• Eramo A , LottiF, SetteGet al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ.15(3), 504–514 (2007).
   PubMed Web of Science ®Google Scholar
• Fang D , NguyenTK, LeishearKet al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res.65(20), 9328–9337 (2005).
   PubMed Web of Science ®Google Scholar
• Collins AT , BerryPA, HydeCet al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res.65(23), 10946–10951 (2005).
   PubMed Web of Science ®Google Scholar
• Prince ME , SivanandanR, KaczorowskiAet al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA104(3), 973–978 (2007).
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L , LombardiDG, PilozziEet al. Identification and expansion of human colon-cancer-initiating cells. Nature445(7123), 111–115 (2006).
   PubMed Web of Science ®Google Scholar
• Singh SK , ClarkeID, TerasakiMet al. Identification of a cancer stem cell in human brain tumors. Cancer Res.63(18), 5821–5828 (2003).
   PubMed Web of Science ®Google Scholar
• Boiko AD , RazorenovaOV, van de RijnMet al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature466(7302), 133–137 (2010).
   PubMed Web of Science ®Google Scholar
• Cheli Y , BonnaziVF, JacquelAet al. CD271 is an imperfect marker for melanoma initiating cells. Oncotarget5(14), 5272–83 (2014).
   PubMedGoogle Scholar
• Civenni G , WalterA, KobertNet al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res.71(8), 3098–3109 (2011).
   PubMed Web of Science ®Google Scholar
• Cragg MS , WalsheCA, IvanovAOet al. The biology of CD20 and its potential as a target for mAb therapy. Curr. Dir. Autoimmun.8, 140–74 (2005).
   PubMedGoogle Scholar
• Luo Y , DallaglioK, ChenYet al. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells30(10), 2100–2113 (2012).
   PubMed Web of Science ®Google Scholar
• Redmer T , WelteY, BehrensDet al. The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells. PloS ONE9(5), e92596 (2014).
   PubMed Web of Science ®Google Scholar
• Khoei S , GoliaeiB, Neshasteh-RizAet al. The role of heat shock protein 70 in the thermoresistance of prostate cancer cell line spheroids. FEBS Lett.561(1–3), 144–148 (2004).
   PubMed Web of Science ®Google Scholar
• Atlasi Y , MowlaSJ, ZiaeeSAet al. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int. J. Cancer120(7), 1598–1602 (2007).
   PubMed Web of Science ®Google Scholar
• Madjd Z , MehrjerdiAZ, SharifiAMet al. CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours. Cancer Immun.9(1), 4 (2009).
   PubMedGoogle Scholar
• Madjd Z , KarimiA, MolanaeSet al. BRCA1 protein expression level and CD44+ phenotype in breast cancer patients. Cell J.13(3), 155–162 (2011).
   PubMed Web of Science ®Google Scholar
• Madjd Z , RamezaniB, MolanaeSet al. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas. Asian Pac. J. Cancer Prev.13(6), 2973–2978 (2012).
   PubMedGoogle Scholar
• Goodarzi N , GhahremaniMH, AminiMet al. CD44-Targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system. Chem. Biol. Drug Des.83(6), 741–752 (2014).
   PubMed Web of Science ®Google Scholar
• Sajadian S , VatankhahM, MajdzadehMet al. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells. Toxicol. Mech. Methods25(5), 388–395 (2015).
   PubMed Web of Science ®Google Scholar
• Ahmadipour F , NoordinMI, MohanSet al. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44+/CD24−/low): an in vitro study. Drug Des. Devel. Ther.9, 1193–1208 (2015).
   PubMed Web of Science ®Google Scholar
• Fazilaty H , GardanehM, AkbariPet al. SLUG and SOX9 cooperatively regulate tumor initiating niche factors in breast cancer. Cancer Microenviron.9(1), 71–74 (2016).
   PubMed Web of Science ®Google Scholar
• Abdollahi P , EbrahimiM, MotamedNet al. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468. Anticancer Drugs26(5), 487–497 (2015).
   PubMed Web of Science ®Google Scholar
• Alibolandi M , RamezaniM, SadeghiFet al. Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Int. J. Pharm.479(1), 241–251 (2015).
   PubMed Web of Science ®Google Scholar
• Nami B , Ghasemi-DizgahA, VaseghiA. Overexpression of molecular chaperons GRP78 and GRP94 in CD44hi/CD24lo breast cancer stem cells. Bioimpacts6(2), 105–110 (2016).
   PubMedGoogle Scholar
• Fani S , DehghanF, KarimianHet al. Monobenzyltin complex C1 induces apoptosis in MCF-7 breast cancer cells through the intrinsic signaling pathway and through the targeting of MCF-7-derived breast cancer stem cells via the Wnt/β-catenin signaling pathway. PLoS ONE11(8), e0160836 (2016).
   PubMed Web of Science ®Google Scholar
• Shabani Ravari N , GoodarziN, AlvandifarFet al. Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells. Daru.24(1), 21 (2016).
   PubMedGoogle Scholar
• Afzali M , VatankhahM, OstadSN. Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7. J. Cancer Res. Ther.12(2), 725–730 (2016).
   PubMed Web of Science ®Google Scholar
• Mohammadi Yeganeh S , VaseiM, TavakoliRet al. The effect of miR-340 over-expression on cell-cycle–related genes in triple-negative breast cancer cells. Eur. J. Cancer Care (Engl). doi: 10.1111/ecc.12496 (2016) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Kalanaky S , HafiziM, FakharzadehSet al. BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo. Drug Des. Devel. Ther.10, 59–70 (2015).
   PubMed Web of Science ®Google Scholar
• Rashidi N , OmidvarR, Tafazzoli-shadpourMet al. Evaluation of elastic properties of breast cancer stem-like/tumor initiating cells using atomic force microscopy. Presented at: Biomedical Engineering (ICBME), 21th Iranian Conference on 2014. IEEE, 134–137 (2014).
   Google Scholar
• Motovali-Bashi M , KouhkanF, HojatiZ. The role of SNP in fibroblast collagenase gene with increasing of metastasis risk and viability reduction in breast cancer patients. JCMR26(3), 365–377 (2013).
   Google Scholar
• Asadi MH , MowlaSJ, FathiFet al. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Int. J. Cancer128(11), 2645–2652 (2011).
   PubMed Web of Science ®Google Scholar
• Nikpour P , Emadi-BaygiM, Mohammad-HashemFet al. Differential expression of ZFX gene in gastric cancer. J. Biosci.37(1), 85–90 (2012).
   PubMed Web of Science ®Google Scholar
• Nosrati A , NaghshvarF, KhanariS. Cancer stem cell markers CD44, CD133 in primary gastric adenocarcinoma. Int. J. Mol. Cell Med.3(4), 279–286 (2014).
   PubMedGoogle Scholar
• Golestaneh AF , AtashiA, LangroudiLet al. miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45. Cell Biochem. Funct.30(5), 411–418 (2012).
   PubMed Web of Science ®Google Scholar
• Momenzadeh D , RahmanzadehS, Rezaei-TaviraniM. ZNF797 plays an oncogenic role in gastric cancer. Genet. Mol. Res.13(4), 8421–8427 (2014).
   PubMed Web of Science ®Google Scholar
• Asadi MH , DerakhshaniA, MowlaSJ. Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma. Tumour Biol.35(7), 7177–7185 (2014).
   PubMedGoogle Scholar
• Najafzadeh N , MazaniM, AbbasiA. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44+ cancer stem cells. Biomed. Pharmacother.74, 243–251 (2015).
   PubMed Web of Science ®Google Scholar
• Emadi-Baygi M , NikpourP, Mohammad-HashemFet al. MSI2 expression is decreased in grade II of gastric carcinoma. Pathol. Res. Pract.209(11), 689–691 (2013).
   PubMed Web of Science ®Google Scholar
• Nikpour P , Emadi-BaygiM, Mohhamad-HashemFet al. MSI1 overexpression in diffuse type of gastric cancer. Pathol. Res. Pract.209(1), 10–13 (2013).
   PubMed Web of Science ®Google Scholar
• Khalili M , SadeghizadehM, GhorbanianKet al. Down-regulation of miR-302b, an ESC-specific microRNA, in gastric adenocarcinoma. Cell J.13(4), 251–258 (2012).
   PubMed Web of Science ®Google Scholar
• Hajimoradi M , Mohammad HassanZ, EbrahimiMet al. STAT3 is overactivated in gastric cancer stem-like cells. Cell J.17(4), 617–628 (2016).
   PubMed Web of Science ®Google Scholar
• Shahhoseini Z , JeivadF, AhangarNet al. Different genotype of rs3130932 single nucleotide polymorphism between gastric cancer patients and normal subjects. J. Gastrointest. Cancer48(1), 38–41 (2017).
   PubMedGoogle Scholar
• Khalili M , VaseiM, KhaliliDet al. Downregulation of the genes involved in reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in gastric adenocarcinoma. J. Gastrointest. Cancer46(3), 251–258 (2015).
   PubMedGoogle Scholar
• Gharagozloo M , MirzaeiHR, BagherpourBet al. Cell cycle analysis of the CD133+ and CD133-cells isolated from human colorectal cancer. J. Cancer Res. Ther.8(3), 399–403 (2012).
   PubMed Web of Science ®Google Scholar
• Shafaei S , SharbatdaranM, KamraniGet al. The association between CD166 detection rate and clinicopathologic parameters of patients with colorectal cancer. Caspian J. Intern. Med.4(4), 768–772 (2013).
   PubMedGoogle Scholar
• Shakibaei M , BuhrmannC, KraehePet al. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures. PLoS ONE9(1), e85397 (2014).
   PubMed Web of Science ®Google Scholar
• Buhrmann C , KraeheP, LuedersCet al. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS ONE9(9), e107514 (2014).
   PubMed Web of Science ®Google Scholar
• Khorrami S , Zavaran HosseiniA, JavadSet al. Identification and characterization of colon cancer stem cells in HT-29 adenocarcinoma cell line. AMUJ17(5), 21–30 (2014).
   Google Scholar
• Mirzaei A , TavoosidanaG, ModarressiMHet al. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Tumour Biol.36(6), 4801–4810 (2015).
   PubMedGoogle Scholar
• Mirzaei A , TavoosidanaG, RadAAet al. A new insight into cancer stem cell markers: could local and circulating cancer stem cell markers correlate in colorectal cancer? Tumour Biol. 37(2), 2405–2414 (2016).
   PubMedGoogle Scholar
• Nosrati A , NaghshvarF, TorabizadehZet al. Correlation of Colorectal cancer stem cell marker CD24 expression with clinicopathologic features and survival of patients with colorectal cancer. Govaresh19(2), 86–94 (2014).
   Google Scholar
• Atashpour S , FouladdelS, MovahhedTKet al. Quercetin induces cell cycle arrest and apoptosis in CD133+ cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin. Iran J. Basic Med. Sci.18(7), 635–43 (2015).
   PubMed Web of Science ®Google Scholar
• Forghanifard MM , MoghbeliM, RaeisossadatiRet al. Role of SALL4 in the progression and metastasis of colorectal cancer. J. Biomed. Sci.20, 6 (2013).
   PubMed Web of Science ®Google Scholar
• Talebi A , KianersiK, BeiraghdarM. Comparison of gene expression of SOX2 and OCT4 in normal tissue, polyps, and colon adenocarcinoma using immunohistochemical staining. Adv. Biomed. Res.4, 234 (2015).
   PubMedGoogle Scholar
• Khorrami S , Zavaran HosseiniA, MowlaSJet al. Verification of ALDH activity as a biomarker in colon cancer stem cells-derived HT-29 cell line. Iran J. Cancer Prev.8(5), e3446 (2015).
   PubMedGoogle Scholar
• Arabi L , BadieeA, MosaffaFet al. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. J. Control Release.220(Pt A), 275–286 (2015).
   PubMed Web of Science ®Google Scholar
• Arab-Bafrani Z , Shahbazi-GahroueiD, AbbasianMet al. Culturing in serum-free culture medium on collagen type-I-coated plate increases expression of CD133 and retains original phenotype of HT-29 cancer stem cell. Adv. Biomed. Res.5, 59 (2016).
   PubMedGoogle Scholar
• Nosrati A , NaghshvarF, MalekiIet al. Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran. Gastroenterol. Hepatol. Bed. Bench.9(2), 132–139 (2016).
   PubMedGoogle Scholar
• Sam S , SamMR, EsmaeillouMet al. Effective targeting survivin, caspase-3 and microRNA-16–1 expression by methyl-3-pentyl-6-methoxyprodigiosene triggers apoptosis in colorectal cancer stem-like cells. Pathol. Oncol. Res.22(4), 715–723 (2016).
   PubMed Web of Science ®Google Scholar
• Sam MR , AhangarP, NejatiVet al. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation. Cell Oncol. (Dordr).39(1), 69–77 (2016).
   PubMed Web of Science ®Google Scholar
• Daman Z , MontazeriH, AziziMet al. Polymeric micelles of PEG-PLA copolymer as a carrier for salinomycin against gemcitabine-resistant pancreatic cancer. Pharm. Res.32(11), 3756–3767 (2015).
   PubMed Web of Science ®Google Scholar
• Saboor-Maleki S , RassouliFB, MatinMMet al. Auraptene attenuates malignant properties of esophageal stem-like cancer cells. Technol. Cancer Res. Treat. pii:1533034616650119 (2016) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Rad A , Esmaeili DizghandiS, AbbaszadeganMRet al. SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinoma. Gene594(2), 171–175 (2016).
   PubMed Web of Science ®Google Scholar
• Moghbeli M , ForghanifardMM, AarabiAet al. Clinicopathological sex-related relevance of Musashi1 mRNA expression in esophageal squamous cell carcinoma patients. Pathol. Oncol. Res.20(2), 427–433 (2014).
   PubMed Web of Science ®Google Scholar
• Moghbeli M , RadA, FarshchianMet al. Correlation between Meis1 and Msi1 in esophageal squamous cell carcinoma. J. Gastrointest. Cancer47(3), 273–277 (2016).
   PubMedGoogle Scholar
• Moghbeli M , AbbaszadeganMR, GolmakaniEet al. Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma. J. Cell Commun. Signal.10(2), 129–135 (2016).
   PubMed Web of Science ®Google Scholar
• Shahryari A , RafieeMR, FouaniYet al. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells32(1), 126–134 (2014).
   PubMed Web of Science ®Google Scholar
• Forghanifard MM , TalebS, AbbaszadeganMR. Notch signaling target genes are directly correlated to esophageal squamous cell carcinoma tumorigenesis. Pathol. Oncol. Res.21(2), 463–467 (2015).
   PubMed Web of Science ®Google Scholar
• Forghanifard MM , Ardalan KhalesS, Javdani-MallakAet al. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma. Med. Oncol.31(4), 922 (2014).
   PubMed Web of Science ®Google Scholar
• Rassouli FB , MatinMM, BahramiARet al. Evaluating stem and cancerous biomarkers in CD15+ CD44+ KYSE30 cells. Tumour Biol.34(5), 2909–2920 (2013).
   PubMedGoogle Scholar
• Saboormaleki S , Behnam RassouliF, Moghaddam MatinMet al. Anticancer effects of valproic acid on esophageal stem-like carcinoma cells. Prog. Biochem. Biophys.43(9), 903–909 (2016).
   Web of Science ®Google Scholar
• Shojaie N , GhaffariSM. Simultaneous analysis of Wnt and NF-κB signaling pathways in doxorubicin sensitive and methotrexate resistant PLC/PRF/5 cells. Cell J.17(4), 730–739 (2016).
   PubMed Web of Science ®Google Scholar
• Hatefi N , NouraeeN, ParvinMet al. Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer. Iran J. Basic Med. Sci.15(6), 1154–1161 (2012).
   PubMed Web of Science ®Google Scholar
• Keymoosi H , GheytanchiE, AsgariMet al. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder. Asian Pac. J. Cancer Prev.15(5), 2013–2020 (2013).
   Google Scholar
• Nikpour P , MowlaSJ, Forouzandeh-MoghaddamMet al. The stem cell self-renewal gene, Musashi1, is highly expressed in tumor and non-tumor samples of human bladder. Indian J. Cancer50(3), 214–218 (2013).
   PubMed Web of Science ®Google Scholar
• Sedaghat S , GheytanchiE, AsgariMet al. Expression of cancer stem cell markers OCT4 and CD133 in transitional cell carcinomas. Appl. Immunohistochem. Mol. Morphol.25(3), 196–202 (2017).
   PubMedGoogle Scholar
• Nikpour P , BaygiME, SteinhoffCet al. The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells. J. Cell. Mol. Med.15(5), 1210–1224 (2011).
   PubMed Web of Science ®Google Scholar
• Monajemzadeh M , SoleimaniV, VaseiMet al. Expression and prognostic significance of Oct4 and Nanog in neuroblastoma. APMIS122(9), 734–741 (2014).
   PubMed Web of Science ®Google Scholar
• Rahman M , ReynerK, DeleyrolleLet al. Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines. Anat. Cell Biol.48(1), 25–35 (2015).
   PubMedGoogle Scholar
• Rafiee MR , Malekzadeh ShafaroudiA, RohbanSet al. Enrichment of a rare subpopulation of miR-302-expressing glioma cells by serum deprivation. Cell J.16(4), 494–505 (2015).
   PubMed Web of Science ®Google Scholar
• Asadi MH , KhalifehK, MowlaSJ. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells. J. Neurooncol.130(3), 455–463 (2016).
   PubMed Web of Science ®Google Scholar
• Malakootian M , MowlaSJ, SaberiHet al. Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors. Mol. Carcinog.49(9), 818–825 (2010).
   PubMed Web of Science ®Google Scholar
• Sabet MN , RakhshanA, ErfaniEet al. Co-expression of putative cancer stem cell markers, CD133 and nestin, in skin tumors. Asian Pac. J. Cancer Prev.15(19), 8161–8169 (2013).
   Google Scholar
• Erfani E , RoudiR, RakhshanAet al. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes. Int. J. Biol. Markers.31(1), e53–e61 (2016).
   PubMed Web of Science ®Google Scholar
• Fomeshi MR , EbrahimiM, MowlaSJet al. Evaluation of the experssions pattern of mir-10b, 21, 200c, 373 and 520c to find the correlation between epithelialto-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells. Cell Mol. Biol. Lett.20(3), 448–465 (2015).
   PubMed Web of Science ®Google Scholar
• Rajabi Fomeshi M , EbrahimiM, MowlaSJ. Differential expression of OCT4 variants in melanomaStem Cells. Cell J.15, 71 (2013).
   Google Scholar
• Roudi R , EbrahimiM, SabetMNet al. Comparative gene-expression profiling of CD133+ and CD133-D10 melanoma cells. Future Oncol.11(17), 2383–2393 (2015).
   PubMed Web of Science ®Google Scholar
• Sabet MN , RoudiR, EbrahimiMet al. Evaluating the expression of putative stem cell markers ALDH1 and CD133 in melanoma cell lines A375 and D10. Razi J. Med. Sci.22(133), 8–15 (2015).
   Google Scholar
• Dashti A , EbrahimiM, HadjatiJet al. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses. Cancer Lett.374(1), 175–185 (2016).
   PubMed Web of Science ®Google Scholar
• Roudi R , MadjdZ, KorourianAet al. Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer. Cancer Biomark.14(6), 457–467 (2014).
   PubMed Web of Science ®Google Scholar
• Roudi R , KorourianA, ShariftabriziAet al. differential expression of cancer stem cell markers aldh1 and cd133 in various lung cancer subtypes. Cancer Invest.33(7), 294–302 (2015).
   PubMed Web of Science ®Google Scholar
• Roudi R , MadjdZ, EbrahimiMet al. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549. Cell Mol. Biol. Lett.19(1), 23–36 (2014).
   PubMed Web of Science ®Google Scholar
• Roudi R , MadjdZ, EbrahimiMet al. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma. Tumour Biol.37(9), 11843–11859 (2016).
   PubMedGoogle Scholar
• Saghaeian Jazi M , SamaeiNM, GhaneiMet al. Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer. Tumour Biol.37(8), 10329–10338 (2016).
   PubMedGoogle Scholar
• Haghpanah V , FallahP, TavakoliRet al. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer. Tumour Biol.37(1), 1299–12308 (2016).
   PubMedGoogle Scholar
• Mehrazma M , MadjdZ, KalantariEet al. Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray. Fetal. Pediatr. Pathol.32(3), 192–204 (2013).
   PubMed Web of Science ®Google Scholar
• Rasti A , AbolhasaniM, ZanjaniLSet al. Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma. J. Cancer. Res. Clin. Oncol.143(1), 95–104 (2017).
   PubMed Web of Science ®Google Scholar
• Kalantari E , SaadiFH, AsgariMet al. Increased expression of aldh1a1 in prostate cancer is correlated with tumor aggressiveness: a tissue microarray study of Iranian patients. Appl Immunohistochem. Mol Morphol. doi:10.1097/PAI.0000000000000343 (2016) (Epub ahead of print).
   Google Scholar
• Jafari Malek S , KhoshchehrehR, GoodarziNet al. cis-Dichlorodiamminoplatinum (II) glyconanoparticles by drug-induced ionic gelation technique targeted to prostate cancer: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces.122, 350–358 (2014).
   PubMed Web of Science ®Google Scholar
• Babashah S , SadeghizadehM, HajifathaliAet al. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells. Int. J. Cancer133(3), 579–589 (2013).
   PubMed Web of Science ®Google Scholar
• Hosseinpour B , BakhtiarizadehMR, MirabbassiSMet al. Comparison of hematopoietic cancer stem cells with normal stem cells leads to discovery of novel differentially expressed SSRs. Gene550(1), 10–17 (2014).
   PubMed Web of Science ®Google Scholar
• Anbarlou A , AtashiA, SoleimaniMet al. Differential characteristics of CD133+ and CD133− Jurkat cells. In vitro Cell Dev. Biol. Anim.51(6), 556–561 (2015).
   PubMed Web of Science ®Google Scholar
• Mohammadi S , GhaffariSH, ShaieganMet al. Curcumin veto the effects of osteopontin (OPN) specific inhibitor on leukemic stem cell colony forming potential via promotion of opn overexpression. Int. J. Hematol. Oncol. Stem Cell. Res.10(3), 120–129 (2016).
   PubMedGoogle Scholar
• Moradi-Kalbolandi S , DavaniD, GolkarMet al. Soluble expression and characterization of a new scFv directed to human CD123. Appl. Biochem. Biotechnol.178(7), 1390–406 (2016).
   PubMed Web of Science ®Google Scholar
• Poursani EM , Mohammad SoltaniB, MowlaSJ. Differential expression of OCT4 pseudogenes in pluripotent and tumor cell lines. Cell J.18(1), 28–36 (2016).
   PubMed Web of Science ®Google Scholar
• Saghaeian Jazi M , SamaeiNM, GhaneiMet al. Identification of new SOX2OT transcript variants highly expressed in human cancer cell lines and down regulated in stem cell differentiation. Mol. Biol. Rep.43(2), 65–72 (2016).
   PubMed Web of Science ®Google Scholar
• Yousefi-Rad N , ShokrgozarMA, BehdaniMet al. Antigenic assessment of a recombinant human CD90 protein expressed in prokaryotic expression system. Protein Expr. Purif.116, 139–143 (2015).
   PubMed Web of Science ®Google Scholar
• Rassouli FB , MatinMM, BahramiARet al. SOX2 expression in gastrointestinal cancers of Iranian patients. Int. J. Biol. Markers30(3), e315–e320 (2015).
   PubMed Web of Science ®Google Scholar
• Rad SM , BamdadT, SadeghizadehMet al. Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy. Tumour Biol.36(4), 2621–2629 (2015).
   PubMedGoogle Scholar
• Ahmadi A , PoorfathollahAA, AghaiipourMet al. Diagnostic value of CD117 in differential diagnosis of acute leukemias. Tumour Biol.35(7), 6763–6768 (2014).
   PubMedGoogle Scholar
• Amini S , FathiF, MobalegiJet al. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat. Cell Biol.47(1), 1–11 (2014).
   PubMedGoogle Scholar
• Favaedi R , ShahhoseiniM, AkhoondMR. Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions. Mol. Cell Biochem.363(1–2), 129–134 (2012).
   PubMed Web of Science ®Google Scholar
• Shahali M , Kabir-SalmaniM, NayerniaKet al. A novel in vitro model for cancer stem cell culture using ectopically expressed piwil2 stable cell line. Cell J.15(3), 250–257 (2013).
   PubMed Web of Science ®Google Scholar
• Meacham CE , MorrisonSJ. Tumour heterogeneity and cancer cell plasticity. Nature501(7467), 328–337 (2013).
   PubMed Web of Science ®Google Scholar
• Kim MP , FlemingJB, WangHet al. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS ONE6(6), e20636 (2011).
   PubMed Web of Science ®Google Scholar
• Li C , HeidtDG, DalerbaPet al. Identification of pancreatic cancer stem cells. Cancer Res.67(3), 1030–1037 (2007).
   PubMed Web of Science ®Google Scholar
• O'Brien CA , PollettA, GallingerSet al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature445(7123), 106–110 (2007).
   PubMed Web of Science ®Google Scholar
• Lapidot T , SirardC, VormoorJet al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature367(6464), 645–648 (1994).
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV . Cancer stem cell and cancer stemloids: from biology to therapy. Cancer Biol. Ther.6(11), 1684–1690 (2007).
   PubMed Web of Science ®Google Scholar
• Visvader JE , LindemanGJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer8(10), 755–768 (2008).
   PubMed Web of Science ®Google Scholar
• Li Y , RogoffHA, KeatesSet al. Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proc. Natl Acad. Sci. USA112(6), 1839–1844 (2015).
   PubMed Web of Science ®Google Scholar
• Maccalli C , De MariaR. Cancer stem cells: perspectives for therapeutic targeting. Cancer Immunol. Immunother.64(1), 91–97 (2015).
   PubMed Web of Science ®Google Scholar
• Matchett KB , LappinTR. Concise reviews: cancer stem cells: from concept to cure. Stem Cells32(10), 2563–2570 (2014).
   PubMed Web of Science ®Google Scholar
• Gheisari Y , BaharvandH, NayerniaKet al. Stem cell and tissue engineering research in the Islamic Republic of Iran. Stem Cell Rev.8(3), 629–639 (2012).
   Web of Science ®Google Scholar
• Zahra SA , MuzavirSR, AshrafSet al. Stem cell research in pakistan; past, present and future. Int. J. Stem. Cells8(1), 1–8 (2015).
   PubMed Web of Science ®Google Scholar
• Massarrat S , KolahdoozanS. Critical assessment of progress of medical sciences in Iran and Turkey: the way developing countries with limited resources should make effective contributions to the production of science. Arch. Iran Med.14(6), 370–377 (2011).
   PubMed Web of Science ®Google Scholar
• Saeidnia S , AbdollahiM. Consequences of international sanctions on Iranian scientists and the basis of science. Hepat. Mon.13(9), e14843 (2013).
   PubMed Web of Science ®Google Scholar
• Gustafsson B . Sanctions against scientists threaten progress. Nature461(7265), 723 (2009).
   PubMed Web of Science ®Google Scholar
• Dou J , GuN. Emerging strategies for the identification and targeting of cancer stem cells. Tumour Biol.31(4), 243–253 (2010).
   PubMed Web of Science ®Google Scholar
• Nakanishi Y , SenoH, FukuokaAet al. Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat. Genet.45(1), 98–103 (2013).
   PubMed Web of Science ®Google Scholar
• Wong DJ , LiuH, RidkyTWet al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell2(4), 333–344 (2008).
   PubMed Web of Science ®Google Scholar
• Dragu DL , NeculaLG, BleotuCet al. Therapies targeting cancer stem cells: current trends and future challenges. World J. Stem Cells7(9), 1185–1201 (2015).
   PubMed Web of Science ®Google Scholar
• Hu Y , FuL. Targeting cancer stem cells: a new therapy to cure cancer patients. Am. J. Cancer Res.2(3), 340–356 (2012).
   PubMed Web of Science ®Google Scholar
• Khan S , KarmokarA, HowellsLet al. Targeting cancer stem-like cells using dietary-derived agents – where are we now? Mol. Nutr. Food Res. 60(6), 1295–1309 (2016).
   PubMed Web of Science ®Google Scholar
• Jung Y , KimWY. Cancer stem cell targeting: are we there yet?Arch. Pharm. Res.38(3), 414–422 (2015).
   PubMed Web of Science ®Google Scholar
• Eccles SA , AboagyeEO, AliSet al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res.15(5), R92 (2013).
   PubMed Web of Science ®Google Scholar